ZyVersa Therapeutics Inc.

NASDAQ: ZVSA · Real-Time Price · USD
0.63
-0.02 (-2.48%)
At close: Jun 23, 2025, 3:56 PM
0.66
6.28%
Pre-market: Jun 24, 2025, 06:10 AM EDT
-2.48%
Bid 0.61
Market Cap 2.99M
Revenue (ttm) n/a
Net Income (ttm) -4.66B
EPS (ttm) -4.68
PE Ratio (ttm) -0.13
Forward PE -0.01
Analyst Strong Buy
Ask 0.66
Volume 204,019
Avg. Volume (20D) 3,767,269
Open 0.65
Previous Close 0.65
Day's Range 0.62 - 0.67
52-Week Range 0.47 - 6.30
Beta 0.74

About ZVSA

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZVSA
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ZVSA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
+24.24%
ZyVersa Therapeutics shares are trading higher aft... Unlock content with Pro Subscription
7 months ago
+39.56%
ZyVersa Therapeutics shares are trading higher after the company highlighted data showing the potential of inflammasome inhibition to protect pancreatic islet beta cells and attenuate progression from obesity to insulin resistance and type 2 diabetes.